To the best of our knowledge, IL-5, G-CSF, and CCL11/eotaxin-1 concentrations emerge as inflammatory mediators associated with the coexistence of T2DM in patients with CAD for the first time. This evidence concerns the gene IL5 and type 2 diabetes mellitus.